A naturalistic study of risperidone maintenance treatment of outpatients with severe mental illness

Psychiatric Services

Volumn 50, Issue 8, 1999, Pages 1084-1086

  Megna, James L ^a,b   Dewan, Mantosh ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b Hutchings Psychiatric Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; MAINTENANCE THERAPY; MALE; OUTPATIENT CARE; SCHIZOIDISM; SCHIZOPHRENIA; SCORING SYSTEM; TARDIVE DYSKINESIA; TREATMENT OUTCOME;

EID: 0032867836     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.50.8.1084     Document Type: Article

References (10)

1. Kane J, Honigfeld G, Singer J, et al: Clozapine for the treatment-resistant schizophrenic: a double-blind comparison versus chlorpromazine/benzotropine. Archives of General Psychiatry 45:789-796, 1988
2. Hagger C, Buckley P, Kerry JT, et al: Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biological Psychiatry 34:702-712, 1993
3. Brier A, Buchanan RW, Irish D, et al: Clozapine in schizophrenic outpatients II: outcome and long-term response patterns. Hospital and Community Psychiatry 44: 1145-1154, 1993
4. Chouinard G, Jones B, Remington G, et al: A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. Journal of Clinical Psychopharmacology 13:25-40, 1993
5. Beasley CM Jr, Hamilton SH, Crawford AM, et al: Olanzapine versus haloperidol: acute-phase results of the international double-blind olanzapine trial. European Neuropsychopharmacology 7:125-127, 1997
6. Arvanitis LA, Miller BG: Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. Biological Psychiatry 42:233-246, 1997
7. Bressa GM, Bersani G, Meco G, et al: One-year follow-up study with risperidone in chronic schizophrenia. New Trends in Experimental Clinical Psychiatry 7:169-177, 1991
8. Addington DE, Jones B, Bloom E, et al: Reduction of hospital days in chronic schizophrenic patients treated with risperidone: a retrospective study. Clinical Therapeutics 15:917-926, 1993
9. Tollefson GD, Beasley CM Jr, Tran PV, et al: Olanzapine versus haloperidol in the treatment of schizophrenia and schizophreniform disorders: results of an international collaborative trial. American Journal of Psychiatry 154:457-465, 1997
10. Lieberman JA, Korun AH, Chakos M, et al: Factors influencing treatment response and outcome of first-episode schizophrenia: implication for understanding the pathophysiology of schizophrenia: Journal of Clinical Psychiatry 57(suppl 9):5-9, 1996